These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3222398

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL, Coffey CE, Basuk B, Cavenar JO, Maltbie AA, Zung WW.
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Platelet monoamineoxidase activity in chronic schizophrenics.
    Gerbaldo H, Rozados RV, Filinger EJ.
    Medicina (B Aires); 1985 Feb; 45(1):22-4. PubMed ID: 3880103
    [No Abstract] [Full Text] [Related]

  • 25. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables.
    Buckman TD, Kling A, Sutphin MS, Steinberg A, Eiduson S.
    Psychiatry Res; 1990 Jan; 31(1):1-14. PubMed ID: 1969170
    [Abstract] [Full Text] [Related]

  • 26. Low platelet monoamine oxidase activity and schizophrenia.
    Wyatt RJ, Murphy DL.
    Schizophr Bull; 1976 Jan; 2(1):77-89. PubMed ID: 779021
    [No Abstract] [Full Text] [Related]

  • 27. Kinetic constants of platelet monoamine oxidase in schizophrenia.
    Jackman HL, Meltzer HY.
    Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590
    [Abstract] [Full Text] [Related]

  • 28. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ, Schildkraut JJ, Schatzberg AF, Herzog JM.
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.
    Takahashi S, Yamane H, Tani N.
    Folia Psychiatr Neurol Jpn; 1975 Dec; 29(3):207-14. PubMed ID: 2524
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [The ratio of blood platelet monoamineoxidase to aldehyde reductase activity in paranoid schizophrenia (author's transl)].
    Landowski J, Wontrobski Z.
    Psychiatr Pol; 1981 Dec; 15(2):133-7. PubMed ID: 7312994
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?
    Fleissner A, Seifert R, Schneider K, Eckert W, Fuisting B.
    Eur Arch Psychiatry Neurol Sci; 1987 Dec; 237(1):8-15. PubMed ID: 3480800
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Electrophoresis of platelet monoamine oxidase in schizophrenia and manic-depressive illness.
    Belmaker RH, Ebstein R, Rimon R, Wyatt RJ, Murphy DL.
    Acta Psychiatr Scand; 1976 Jul; 54(1):67-72. PubMed ID: 952234
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.